PortfoliosStock ScreensStocksStockXcel

OKYO Pharma Limited

OKYO | US

1.59

USD

-0.06

-3.64%

OKYO | US

About OKYO Pharma Limited

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2023

As of date

16/04/2026

Close

1.59

Open

1.65

High

1.65

Low

1.59

OKYO Pharma Limited a preclinical biopharmaceutical company engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101 for the treatment of dry eye disease. The company is also developing OK-201 a bovine adrenal medulla lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company was incorporated in 2007 and is headquartered in London the United Kingdom.

View Less

OKYO | US

Risk
54.6
Sharpe
0.44
Luna's Score
45/100
Recommendation
Sell

Luna says (OKYO | US)

What's Working

Low Debt to Equity (< 0.25)

What's not Working

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Low negative Beta, possible Low Liquidity (< -0.4)

Rich in Valuation (Price to Book > 8)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

56.1%

1 month

54.6%

3 months

79.3%

6 months

91.8%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

14.11

Debt to equity

-1.08

Debt to assets

0.43

Ent. to EBITDA

-4.29

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-15.75M

MarketCap

53.80M

MarketCap(USD)

53.80M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

-

Ret. on equity

-2.97K

Short ratio

5.77

Short perc.

0.86

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

0.25

Range1M

0.29

Range3M

1.44

Volumes: Market Activity

Rel. volume

0.53

Price X volume

87.48K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
ImmuCell CorporationICCCBiotechnology7.5459.06M-0.79%n/a67.52%
QNCXQNCXBiotechnology1.3457.99M8.94%n/a30.62%
THL Credit Inc. 6.75% Notes duTCRXBiotechnology1.0857.21M0.93%n/a35.68%
TPSTTPSTBiotechnology2.2456.47M5.66%n/a119.58%
Sangamo Therapeutics IncSGMOBiotechnology0.2756.22M-1.85%n/a122.82%
PEPGPEPGBiotechnology1.6754.42M-2.91%n/a12.52%
Rani Therapeutics Holdings Inc. Class A Common StockRANIBiotechnology0.91953.18M-4.27%n/a1243.32%
Gain Therapeutics Inc. Common StockGANXBiotechnology2.0552.35M-4.21%n/a6.85%
Acrivon Therapeutics Inc.ACRVBiotechnology1.6751.72M0.00%n/a1.95%
Clene Nanomedicine IncCLNNBiotechnology6.3550.56M0.00%n/a-6472.02%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Beasley Broadcast Group IncBBGIBroadcasting - Radio1421.32M2.04%n/a204.46%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.61211.83M-2.84%n/a58.43%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.7410.81M6.52%0.0316.03%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.3353.41M-2.06%n/a17.32%
Twin Vee PowerCats Co. Common StockVEEERecreational Vehicles0.21672.06M-6.19%n/a19.98%
Vision Marine Technologies IncVMARRecreational Vehicles1.44793.44K-17.24%n/a0.00%
Micromobility.com Inc.MCOMRecreational Vehicles0.005461.07K0.00%n/a-37.05%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-4.29-Cheaper
Ent. to Revenue---
PE Ratio-41.03-
Price to Book14.1115.55Par
Dividend Yield---
Std. Deviation (3M)79.33-Par
Debt to Equity-1.08-1.23Cheaper
Debt to Assets0.430.25Expensive
Market Cap53.80M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007